S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
NASDAQ:HZNP

Horizon Therapeutics Public (HZNP) SEC Filings & 10K Form

$115.69
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$115.66
▼
$115.75
50-Day Range
$98.98
▼
$115.74
52-Week Range
$60.03
▼
$115.87
Volume
1.73 million shs
Average Volume
2.33 million shs
Market Capitalization
$26.49 billion
P/E Ratio
61.87
Dividend Yield
N/A
Price Target
$110.71
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Recent Horizon Therapeutics Public SEC Filings

Export to Excel
DateFilerForm TypeView
09/28/2023
3:39 PM		GREY MICHAEL G (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2023
4:13 PM		Himawan Jeff (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2023
6:07 PM		Horizon Therapeutics Public (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
6:30 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
3:15 PM		Horizon Therapeutics Public (Issuer)
SHERMAN JEFFREY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
8:09 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/01/2023
8:21 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
7:14 AM		Horizon Therapeutics Public (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2023
6:11 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
2:31 PM		Horizon Therapeutics Public (Filer)
Form DEF 14A
06/30/2023
2:33 PM		Horizon Therapeutics Public (Filer)
Form ARS
06/05/2023
7:00 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2023
7:01 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2023
6:22 AM		Horizon Therapeutics Public (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2023
6:06 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2023
6:32 PM		Horizon Therapeutics Public (Issuer)
Watkins Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:34 PM		Horizon Therapeutics Public (Issuer)
Witz Pascale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:36 PM		Horizon Therapeutics Public (Issuer)
SANTINI GINO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:17 PM		GREY MICHAEL G (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:21 PM		Himawan Jeff (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:24 PM		Daniel William F (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:26 PM		Horizon Therapeutics Public (Issuer)
Mahony Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2023
6:29 PM		Horizon Therapeutics Public (Issuer)
Shannon James Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2023
7:01 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2023
7:10 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2023
3:48 PM		DesJardin Michael A. (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2023
6:13 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2023
6:24 AM		Horizon Therapeutics Public (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2023
10:22 AM		Horizon Therapeutics Public (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/09/2023
10:18 AM		FMR LLC (Filed by)
Horizon Therapeutics Public (Subject)
Form SC 13G/A
02/08/2023
7:00 AM		Horizon Therapeutics Public (Filer)
Form DEFA14A
02/07/2023
9:33 AM		BlackRock Inc. (Filed by)
Horizon Therapeutics Public (Subject)
Form SC 13G/A
01/31/2023
3:11 PM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2023
3:27 PM		Horizon Therapeutics Public (Filer)
Form DEFA14A
01/23/2023
5:59 AM		Horizon Therapeutics Public (Filer)
Form DEFM14A
01/18/2023
3:19 PM		Horizon Therapeutics Public (Issuer)
Pasternak Andy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2023
3:21 PM		Horizon Therapeutics Public (Issuer)
SHERMAN JEFFREY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2023
7:32 PM		Cox Aaron (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2023
3:29 PM		Horizon Therapeutics Public (Issuer)
SHERMAN JEFFREY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2023
4:56 PM		Horizon Therapeutics Public (Issuer)
McIlvenny Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2023
4:48 PM		Horizon Therapeutics Public (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2023
4:52 PM		DesJardin Michael A. (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2023
4:54 PM		Horizon Therapeutics Public (Issuer)
SHERMAN JEFFREY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2023
4:35 PM		Clayton Sean M. (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2023
4:38 PM		Horizon Therapeutics Public (Issuer)
Pasternak Andy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2023
4:41 PM		Cox Aaron (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2023
4:43 PM		Horizon Therapeutics Public (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2023
3:25 PM		DesJardin Michael A. (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2023
3:27 PM		Horizon Therapeutics Public (Issuer)
SHERMAN JEFFREY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2022
3:11 PM		Horizon Therapeutics Public (Filer)
Form PREM14A
12/29/2022
3:28 PM		Horizon Therapeutics Public (Issuer)
Pasternak Andy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2022
3:31 PM		Horizon Therapeutics Public (Issuer)
SHERMAN JEFFREY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2022
3:33 PM		Horizon Therapeutics Public (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2022
3:23 PM		Cox Aaron (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2022
3:26 PM		DesJardin Michael A. (Reporting)
Horizon Therapeutics Public (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2022
4:10 PM		Horizon Therapeutics Public (Issuer)
Pasternak Andy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2022
3:12 PM		Horizon Therapeutics Public (Issuer)
SHERMAN JEFFREY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2022
4:00 PM		Horizon Therapeutics Public (Filer)
Form DEFA14A
12/12/2022
6:39 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2022
5:31 AM		Horizon Therapeutics Public (Filer)
Form DEFA14A
11/29/2022
4:22 PM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2022
3:12 PM		Horizon Therapeutics Public (Issuer)
Pasternak Andy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2022
6:06 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2022
6:16 AM		Horizon Therapeutics Public (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/07/2022
7:01 AM		Horizon Therapeutics Public (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:HZNP) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -